Protocol Version 3.0 Released

We are happy to announce the news that the PEXIVAS Trial has reached its recruitment target of 500 patients!

The PEXIVAS Trial has now received approval to continue recruitment beyond the original 500 patients. The trial will now recruit 700 patients, extending the recruitment period to December 2016 with a trial end date of December 2017.

A new recruitment target was needed so that the trial is sufficiently large enough for its planned statistical analysis.
The new PEXIVAS protocol that reflects the trial extension was approved on 5th January 2015 by the REC and 11th February 2015 by the MHRA. If you wish to obtain a copy of the PEXIVAS protocol, please contact the BCTU trial office.